The tetraspanin CD9 influences the adhesion, spreading, and pericellular fibronectin matrix assembly of Chinese hamster ovary cells on human plasma fibronectin

Experimental Cell Research

Volumn 251, Issue 2, 1999, Pages 356-371

  Cook, George A ^a   Wilkinson, Deborah A ^a   Crossno Jr , Joseph T ^a   Raghow, Rajendra ^a,b   Jennings, Lisa K ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Cell adhesion; Chinese hamster ovary cells; Extracellular matrix; Integrins; Membrane proteins; Tetraspanins

Indexed keywords

BOVINE SERUM ALBUMIN; CD9 ANTIGEN; COLLAGEN TYPE 4; FIBRONECTIN; MEMBRANE PROTEIN; TETRASPANIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL ADHESION; CELL INTERACTION; CELL SPREADING; CELL SURFACE; CHO CELL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR MATRIX; FLOW CYTOMETRY; IMMUNOFLUORESCENCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN IMMOBILIZATION;

ANIMALIA; BOVINAE; CRICETINAE; CRICETULUS GRISEUS;

EID: 0033567980     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.1999.4596     Document Type: Article

References (54)

1. Forsyth K. D. Anti-CD9 antibodies augment neutrophil adherence to endothelium. Immunology. 72:1991;292-296.
2. Jennings L. K., Crossno J. T. Jr., White M. M. Further characterization of the adhesive properties of CD9 and identification of CD9-fibronectin contact sites. Blood. 88:1996;624a.
3. Rubinstein E., Le Naour F., Billard M., Prenant M., Boucheix C. CD9 antigen is an accessory subunit of the VLA integrin complexes. Eur. J. Immunol. 24:1994;3005-3013.
4. Nakamura K., Iwamoto R., Mekada E. Membrane-anchored heparin-binding EGF-like growth factor (HB-EGF) and diphtheria toxin receptor-associated protein (DRAP27)/CD9 form a complex with integrin alpha 3 beta 1 at cell-cell contact sites. J. Cell Biol. 129:1995;1691-1705.
5. Berditchevski F., Zutter M. M., Hemler M. E. Characterization of novel complexes on the cell surface between integrins and proteins with 4 transmembrane domains (TM4 proteins). Mol. Biol. Cell. 7:1996;193-207.
6. Radford K. J., Thorne R. F., Hersey P. CD63 associates with transmembrane 4 superfamily members, CD9 and CD81, and with beta 1 integrins in human melanoma. Biochem. Biophys. Res. Commun. 222:1996;13-28.
7. Rubinstein E., Le Naour F., Lagaudriere-Gesbert C., Billard M., Conjeaud H., Boucheix C. CD9, CD63, CD81, and CD82 are components of a surface tetraspan network connected to HLA-DR and VLA integrins. Eur. J. Immunol. 26:1996;2657-2665.
8. Hadjiargyrou M., Kaprielian Z., Kato N., Patterson P. H. Association of the tetraspan protein CD9 with integrins on the surface of S-16 Schwann cells. J. Neurochem. 67:1996;2505-2513.
9. IIIa can be topographically associated and transduce functionally similar signals. Eur. J. Biochem. 244:1997;168-175.
10. Maecker H. T., Todd S. C., Levy S. Tetraspanin superfamily: Molecular facilitators. FASEB J. 11:1997;428-442.
11. Jennings L. K., Fox C. F., Kouns W. C., McKay C. P., Ballou L. R., Schultz H. E. The activation of human platelets mediated by anti-human platelet p24/CD9 monoclonal antibodies. J. Biol. Chem. 265:1989;3815-3822.
12. Griffith L., Slupsky J., Seehafer J., Boshkov L., Shaw A. R. E. Platelet activation by immobilized monoclonal antibody: Evidence for a CD9 proximal signal. Blood. 78:1991;1753-1759.
13. Kroll M. H., Mendolsohn M. E., Miller J. L., Ballen K. K., Hrbolich J. K., Schafer A. I. Monoclonal antibody AG-1 initiates platelet activation by a pathway dependent on glycoprotein IIb-IIIa and extracellular calcium. Biochim. Biophys. Acta. 1137:1992;248-256.
14. Ikeyama S., Koyama M., Yamakao M., Sasada R., Miyake M. Suppression of cell motility and metastasis by transfection with human-motility related protein (MRP-1/CD9) DNA. J. Exp. Med. 177:1993;1231-1237.
15. Miyake M., Nakano K., Ieki Y., Adachi M., Huang C. L., Itoi S., Koh T., Taki T. Motility related protein 1 (MRO/CD9) expression: inverse correlation with metastases in breast cancer. Cancer Res. 55:1995;4127-4131.
16. Shaw A. R. E., Domanska A., Mak A., Gilchrist A., Dobler K., Visser L., Poppema S., Fliegel L., Letarte M., Willet B. J. Ectopic expression of human and feline CD9 in a human B cell line confers beta 1 integrin dependent motility on fibronectin and laminin substrates and enhanced tyrosine phosphorylation. J. Biol. Chem. 270:1995;24092-24099.
17. 3. FASEB J. 9:1995;A1500.
18. Obara M., Kang M. S., Yamada K. M. Site-directed mutagenesis of the cell-binding domain of human fibronectin: Separate, synergistic sites mediate adhesive function. Cell. 53:1988;649-657.
19. Aota S., Nagai T., Yamada K. M. Characterization of regions of fibronectin besides the arginine-glycine-aspartic acid sequence required for adhesive function of the cell-binding domain using site-directed mutagenesis. J. Biol. Chem. 266:1991;15938-15943.
20. Nagai T., Yamada N., Aota S., Yamada S. S., Olden K., Yamada K. M. Monoclonal antibody characterization of two distinct sites required for function of the central cell-binding domain of fibronectin in cell adhesion, cell migration, and matrix formation. J. Cell Biol. 114:1991;1295-1305.
21. Humphries M. J. The molecular basis and specificity of integrin-ligand interactions. J. Cell Sci. 97:1990;585-592.
22. Ruoslahti E. Integrins. J. Clin. Invest. 87:1991;1-5.
23. McDonald J. A., Quade B. J., Broekelmann T. J., LaChance R., Forsman K., Hasegawa E., Akiyama S. K. Fibronectin's cell-adhesive domain and an amino-terminal matrix assembly domain participate in its assembly into fibroblast pericellular matrix. J. Biol. Chem. 262:1987;2957-2967.
24. 1) antibodies. J. Cell Biol. 111:1990;699-708.
25. Yoneda J., Saiki I., Igarashi Y., Kobayadhi H., Fujii H., Ishizaki Y., Kimizuka F., Kato I., Azuma I. Role of the heparin-binding domain of chimeric peptides derived from fibronectin in cell spreading and motility. Exp. Cell Res. 217:1995;169-179.
26. Lanza F., Wolf D., Fox C. F., Kieffer N., Seyer J. M., Fried V. A., Coughlin S. R., Phillips D. R., Jennings L. K. cDNA cloning and expression of platelet p24/CD9: Evidence for a new family of multiple membrane spanning proteins. J. Biol. Chem. 266:1991;10638-10645.
27. Jennings L. K., Crossno J. T. Jr., Fox C. F., White M. M., Green C. A. Platelet p24/CD9, a member of the tetraspanin family of proteins. Ann. N.Y. Acad. Sci. 714:1994;175-184.
28. Quade B. J., McDonald J. A. Fibronectin's amino-terminal matrix assembly site is located within the 29-kD amino-terminal domain containing five type I repeats. J. Biol. Chem. 263:1988;19602-19609.
29. 5 cytoplasmic domain, functions in an early and essential step in fibronectin matrix assembly. J. Biol. Chem. 268:1993;21883-21888.
30. 1 in promoting cellular attachment and spreading on fibronectin. J. Cell Biol. 111:1990;2795-2800.
31. 1 fibronectin receptor suppress the transformed phenotype of Chinese hamster ovary cells. Cell. 60:1990;849-859.
32. Schreiner C. L., Bauer J. S., Danilov T. N., Hussein S., Sczekan M. M., Juliano R. L. Isolation and characterization of Chinese hamster ovary cell variants deficient in the expression of fibronectin receptor. J. Cell Biol. 109:1989;3157-3167.
33. Slupsky J. R., Seehafer J. G., Tang S., Masellis-Smith A., Shaw A. R. E. Evidence that monoclonal antibodies against CD9 antigen induce specific association between CD9 and the platelet glycoprotein IIb-IIIa complex. J. Biol. Chem. 264:1989;12289-12293.
34. Brisson C., Azorsa D. O., Jennings L. K., Moog S., Cazenave J. P., Lanza F. Co-localization of CD9 and GPIIb-IIIa (alpha IIb beta 3 integrin) on activated platelet pseudopods and alpha-granule membranes. Histochem. J. 29:1997;153-165.
35. 3 (GPIIb-IIIa) complex in platelet membranes and transfected cells. Biochem. J. 327:1997;291-298.
36. Anton E. S., Hadjiargyrou M., Patterson P. H., Mathew W. D. CD9 plays a role in Schwann cell migration in vitro. J. Neurosci. 15:1995;584-595.
37. Hadjiargyrou M., Patterson P. H. An anti-CD9 monoclonal antibody promotes adhesion and induces proliferation of Schwann cells in vitro. J. Neurosci. 15:1995;574-583.
38. Schmidt C., Kunemund V., Wintergerst E. S., Schmitz B., Schachner M. CD9 of mouse brain is implicated in neurite outgrowth and cell migration in vitro and is associated with the alpha 6/beta 1 integrin and the neural adhesion molecule L1. J. Neurosci. Res. 43:1996;12-31.
39. Banerjee S. A., Hadjiargyrou M., Patterson P. H. An antibody to the tetraspan membrane protein CD9 promotes neurite formation in a partially alpha3beta1 integrin-dependent manner. J. Neurosci. 17:1997;2756-2765.
40. Bell G. I. Models for the specific adhesion of cells to cells: A theoretical framework for adhesion mediated by reversible bonds between cell surface molecules. Science. 200:1978;618-627.
41. Hammer D. A., Lauffenberger D. A. A dynamical model for receptor-mediated cell adhesion to surfaces. Biophys. J. 52:1987;475-487.
42. 1 integrin-fibronectin bonds in intact adherent cells is sensitive to integrin activation state. J. Biol. Chem. 273:1998;10988-10993.
43. Masellis-Smith A., Shaw A. R. E. CD9-regulated adhesion: Anti-CD9 monoclonal antibody induce pre-B cell adhesion to bone marrow fibroblasts through de novo recognition of fibronectin. J. Immunol. 152:1994;2768-2777.
44. Masellis-Smith A., Jensen G. S., Seehafer J. G., Slupsky J. R., Shaw A. R. E. Anti-CD9 monoclonal antibodies induce homotypic adhesion of pre-B cell lines by a novel mechanism. J. Immunol. 144:1990;1607-1613.
45. Barkalow F. J., Schwarzbauer J. E. Localization of the major heparin-binding site in fibronectin. J. Biol. Chem. 266:1991;7812-7818.
46. Bowditch R. D., Hariharan M., Tominna E. F., Smith J. W., Yamada K. M., Getzoff E. D., Ginsberg M. H. Identification of a novel integrin binding site in fibronectin. J. Biol. Chem. 269:1994;10856-10863.
47. Kimizuka F., Taguchi Y., Ohdate Y., Kawase Y., Shimojo T., Hasino K., Kato I., Sekiguchi K., Titan K. Production and characterization of functional domains of human plasma fibronectin expressed in Escherichia coli. J. Biochem. 110:1991;284-291.
48. Woods A., Couchman J. R., Johnson S., Hook M. Adhesion and cytoskeletal organisation of fibroblasts in response to fibronectin fragments. EMBO J. 5:1986;665-670.
49. Hall M. D., Flickinger K. S., Cutolo M., Zardi L., Culp L. A. Adhesion of human dermal reticular fibroblasts on complementary fragments of fibronectin: Aging in vivo or in vitro. Exp. Cell Biol. 179:1988;115-136.
50. McKeown-Longo P. J., Mosher D. F. Interaction of the 70,000-mol-wt amino terminal fragment of fibronectin with the matrix assembly receptor of fibroblasts. J. Cell Biol. 100:1985;367-374.
51. Roman J., LaChance R. M., Broekelmann T. J., Kennedy C. T. R., Wayne E. A., Carter W. G., McDonald J. A. The fibronectin receptor is organized by extracellular matrix formation: Implications for oncogenic transformation and for cell recognition of fibronectin matrices. J. Cell Biol. 108:1989;2529-2543.
52. Peters D. M., Mosher D. F. Formation of fibronectin extracellular matrix. Yurchenco P. D., Birk D. E., Mechams R. P. Extracellular Matrix Assembly and Structure. 1994;Academic Press, San Diego.
53. Wu C., Keivens V. M., O'Toole T. E., McDonald J. A., Ginsberg M. H. Integrin activation and cytoskeletal interaction are essential for the assembly of a fibronectin matrix. Cell. 83:1995;715-724.
54. Bultmann H., Santas A. J., Peters D. M. Fibronectin fibrillogenesis involves the heparin II binding domain of fibronectin. J. Biol. Chem. 273:1998;2601-2609.